These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11348725)

  • 1. A mathematical model describing the thermal virus inactivation.
    Noël C; Charles S; Françon A; Flandrois JP
    Vaccine; 2001 May; 19(25-26):3575-82. PubMed ID: 11348725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione is a highly efficient thermostabilizer of poliovirus Sabin strains.
    Abdelnabi R; Delang L; Neyts J
    Vaccine; 2017 Mar; 35(10):1370-1372. PubMed ID: 28189401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid and RNA stabilisation of the oral polio vaccine.
    Verheyden B; Andries K; Rombaut B
    Vaccine; 2001 Feb; 19(15-16):1899-905. PubMed ID: 11228359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The thermostability of vaccines. Technologies for improving the thermostability of the oral poliovirus vaccine.
    Lemon SM; Milstien JB
    Int J Technol Assess Health Care; 1994; 10(1):177-84. PubMed ID: 8157450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the failure time of the vaccine vial monitor used for oral poliovirus vaccine at 25 ℃ and 37 ℃].
    Wen CK; Zhou CN; Jiang L; Chen ZG
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Mar; 51(3):248-251. PubMed ID: 28260340
    [No Abstract]   [Full Text] [Related]  

  • 6. The replacement of water with deuterium oxide significantly improves the thermal stability of the oral poliovirus vaccine.
    Crainic R; Wu R; Otelea D; Georgescu MM; Delpeyroux F; Guillot S; Balanant J; Tardy-Panit M
    Dev Biol Stand; 1996; 87():161-6. PubMed ID: 8854013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory considerations for new stabilised poliovaccines.
    Milstien JB; Lemon S
    Dev Biol Stand; 1996; 87():181-9. PubMed ID: 8854016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of stable liquid formulations for adenovirus-based vaccines.
    Evans RK; Nawrocki DK; Isopi LA; Williams DM; Casimiro DR; Chin S; Chen M; Zhu DM; Shiver JW; Volkin DB
    J Pharm Sci; 2004 Oct; 93(10):2458-75. PubMed ID: 15349956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants.
    Migasena S; Simasathien S; Samakoses R; Pitisuttitham P; Sangaroon P; van Steenis G; Beuvery EC; Bugg H; Bishop R; Davidson BL
    Vaccine; 1995 Feb; 13(2):168-74. PubMed ID: 7625111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks.
    Kim JH; Rho SH
    J Theor Biol; 2015 Jan; 364():266-74. PubMed ID: 25264265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of live, freeze-dried virus vaccines.
    Peetermans J; Colinet G; Bouillet A; D'Hondt E; Stephenne J
    Dev Biol Stand; 1976 Oct; 36():291-6. PubMed ID: 1030427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat stability of the lyophilized Sabin poliovaccine.
    Shiomi H; Urasawa T; Urasawa S
    Jpn J Infect Dis; 2003 Apr; 56(2):70-2. PubMed ID: 12824691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced kinetic analysis as a tool for formulation development and prediction of vaccine stability.
    Clénet D; Imbert F; Probeck P; Rahman N; Ausar SF
    J Pharm Sci; 2014 Oct; 103(10):3055-64. PubMed ID: 25139388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilisation of poliovirus with pirodavir.
    Rombaut B; Andries K; Boeyé A
    Dev Biol Stand; 1996; 87():173-80. PubMed ID: 8854015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adverse storage on live virus vaccines.
    Finter NB; Ferris R; Kelly A; Prydie J
    Dev Biol Stand; 1978; 41():271-6. PubMed ID: 753656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
    Fine PE; Carneiro IA
    Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thermal stability of yellow fever vaccines.
    Ishak R; Howard CR
    Mem Inst Oswaldo Cruz; 1990; 85(3):339-45. PubMed ID: 2134708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective molecular and phenotypic analysis of poliovirus vaccine strains isolated in Greece.
    Pliaka V; Filliponi ME; Kyriakopoulou Z; Ruether IG; Tsakogiannis D; Gartzonika C; Levidiotou-Stefanou S; Markoulatos P
    Clin Microbiol Infect; 2011 Oct; 17(10):1554-62. PubMed ID: 21375661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.